InvestorsHub Logo
Followers 839
Posts 120698
Boards Moderated 13
Alias Born 09/05/2002

Re: rwwine post# 16618

Saturday, 02/11/2017 12:37:30 PM

Saturday, February 11, 2017 12:37:30 PM

Post# of 20689
MNTA submitted its 40mg Copaxone ANDA on the first day possible—i.e. immediately after TEVA's (now discredited) 40mg-Copaxone patents were entered into the FDA's Orange Book. So, at worst, MNTA filed on the same day as other 40mg-Copaxone ANDA filers.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”